Halozyme Therapeutics Inc
HALO
|
|
| |
|
| Trading Volume | 69,956 |
|
|
64.96 - 33.32 |
| Market Cap Full | $ 8.4B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | 5.8% | 9.5% | -32.9% |
| Q2 | - | - | 25% | -5.6% |
| Q3 | - | - | 15.3% | 5.9% |
| Q4 | - | - | -21.2% | -1.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 5.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -8.4 | 17.6 | 1.7 | -4.6 | 14.7 | 16.5 | 7.1 | 15.3 | - | - | - | -1.1 |
| 2023 | |||||||||||
| -9 | -7.3 | -20.4 | -15.9 | 0.9 | 11.2 | 19.1 | -0.9 | -10.2 | -11.3 | 14 | -4.3 |
| 2022 | |||||||||||
| -16.7 | 5.9 | 12.4 | 2.9 | 12.3 | -4.6 | 11.1 | -16.7 | -2.9 | 20.9 | 19.8 | -0.6 |
| 2021 | |||||||||||
| 10.4 | -4.3 | -7.5 | 19.3 | -16.7 | 9.1 | -9 | 1.6 | -2.7 | -6.9 | -13.6 | 22.3 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | 0.3 | 0.4 | 0.2 |
| Q2 | 0.6 | 0.2 | 0.6 |
| Q3 | 0.6 | 0.4 | 1.5 |
| Q4 | 0 | 0.4 | 0.5 |
| A | 1.46 | 1.4 | 2.7 |